BioSpace.com News

"Love Hormone" Promises Safer Births After Pfizer Inc. Flop

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A hormone treatment based on technology used in Pfizer (PFE) Inc.s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality. Six years after Pfizer pulled Exubera from the...

A*STAR: A Better Quality of Life, Thanks to the Science of Measurement

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

1. Singapore, 20 May 2013Whether youre comparing the weight of the bak kwa you buy every Chinese New Year, following the doctors prescribed dose of medicine, or determining which light bulb conserves energy...

A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore and Schlieren (Zurich), Switzerland, May 17, 2013 Singapores Agency for Science, Technology and Research (A*STAR) and Switzerlands Cytos Biotechnology AG today announced that the first healthy...

Almac Group Secures New Metagenomics and Enzyme Discovery Program With University College London

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 15, 2013 -- The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme...

A*STAR: Singapore as Asia's Innovation Capital

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

1. SINGAPORE, 15 MAY 2013 Singapore has received recognition in five global tracking studies in the area of Innovation and Research and Development (R&D). After 20 years of long term commitment to Science...

The Uses Nanoparticle Tracking Analysis to Characterize Nanoparticles in Natural Environments

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Salisbury, UK, 14th May, 2013: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being used at the University of Wyoming in the characterization of the physical and interfacial properties of manufactured...

6th Monolith Summer School & Symposium to be Held on May 30th - June 4th, 2014, Slovenia

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ajdovcina, Slovenia, May 14, 2013 / B3C newswire / The 6th Monolith Summer School and Symposium (MSS) will be held from May to June 2014 in Slovenia. Attendees will have an excellent opportunity to expand...

A*STAR's Genome Institute of Singapore Partners to Discover and Monitor Cells for Pathologies or Abnormalities

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore, 10th May 2013 The Genome Institute of Singapore (GIS) from the Agency for Science, Technology and Research (A*STAR) and Oxford Biodynamics (OBD) will collaborate to identify epigenetic signatures...

Institute for Infocomm Research (I2r), Singapore's Largest ICT Research Institute, Collaborates With Globally Competitive Companies and Invents Impactful Technologies Anchored by Scientific Research

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore 8 May 2013 The Institute for Infocomm Research (I2R), a research institute of the Agency for Science, Technology and Research (A*STAR) announced two collaborations with ST Electronics (Info-Comm...

Aesica Partners With the University of Nottingham to Develop Novel Amide Chemical Synthesis Technique

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Newcastle, 7 May 2013: Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond...

DBV Technologies and Mount Sinai Hospital Enter Into a Research Collaboration Agreement

Tue, 07 May 2013 12:00:00 AM GMT

BAGNEUX, FRANCE--(Marketwired - May 07, 2013) - DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today a partnership with the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai (New York) for research related to the mechanism by which epicutaneous immunotherapy...

Shikino High-Tech Kicks Off R&D in Singapore With A*STAR Institute of Microelectronics

Mon, 06 May 2013 12:00:00 AM GMT

1.Singapore, 6 May 2013 Shikino High-Tech Co., Ltd., a market leader in camera systems and image processing modules, with extensive experience in IP core licensing, has signed a research agreement with A*STAR Institute of Microelectronics (IME) to develop a low power and high performance Gyro-sensor ASIC IP block for commercial hand held applications.

2.This agreement marks Shikino High...

Li Ka-Shing Donates $31 Million to Medical Research Institute at Oxford University

Mon, 06 May 2013 12:00:00 AM GMT

by Richard Daverman, PhD

May 3, 2013 -- Li Ka-Shing, the richest man in Asia, has given $31 million to Oxford University in England to fund a new drug discovery and healthcare delivery institute. Mr. Li founded the Hutchison Whampoa conglomerate, which is the corporate parent of Hutchison Chi-Med, one of Chinas leading innovative pharmas. Great Britain is matching his gift with another ...

StemCell Technologies Inc. Obtains License From iPS Academia Japan, Inc. for Induced Pluripotent Stem Cell Technologies

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 01, 2013 -- STEMCELL Technologies Inc. has signed an agreement to license iPS Academia Japans induced pluripotent stem cell (iPS cell) technologies. This agreement will enable STEMCELL Technologies...

University of Science and Technology Researchers Clear Blocked Blood Vessels With Lasers

Mon, 29 Apr 2013 12:00:00 AM GMT

by Richard Daverman, PhD

April 26, 2013 -- Using lasers as optical tweezers, China scientists have picked apart a blockage in the capillaries of a mouse ear, cell by cell. The work was done by Yin-Mei Li, PhD, and her team from the University of Science and Technology in China in Hefei. The researchers explained that the weak forces generated by light passing through molecules were strong...

Evotec AG: New Hormone to Treat Diabetes Published in "

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAMBURG, Germany, April 26, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced an auspicious step in research from Harvard University. The findings are published...

Singapore's and the Norwegian University of Science and Technology Forge Strategic Alliance for Innovation on World IP Day

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

April 26, 2013 -- The Singapore-based non-profit company IPI and NTNU signed a Memorandum of Understanding (MoU) on Friday, 26 April 2013, making NTNU IPIs first Network Partner in the Nordic region. The...

Toumaz Limited Release: SensiumVitals® Pilot Study Demonstrates Significant Improved Patient Care and Hospital Cost Savings

Thu, 25 Apr 2013 12:00:00 AM GMT

Abingdon, UK, 25 April 2013 - Toumaz Limited (AIM: TMZ), a pioneer in low cost, ultra-low power wireless communications technology, announces the results of its pilot study for its SensiumVitals disposable wireless vital signs monitoring solution. The study exceeded expectations with SensiumVitals detecting all patients who experienced deterioration in their condition between routine ward observation...

A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases

Thu, 25 Apr 2013 12:00:00 AM GMT

SINGAPORE--(Marketwired - April 25, 2013) - The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop™, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. ...

Institute of Bioengineering and Nanotechnology Release: Understanding Abnormal Proteins in Degenerative Diseases

Mon, 22 Apr 2013 12:00:00 AM GMT

Singapore, April 22, 2013 Amyloids, or fibrous aggregates of abnormally folded proteins, are a common feature in degenerative diseases such as Alzheimers, diabetes and cancer. Amyloids occur naturally in the body, but despite decades of research, their mechanism of formation remains unknown, hampering drug development efforts. Now, a new class of ultrasmall peptides developed by the Institute of...

Austrian Science Fund FWF: Cold-Blooded Research has Hearts Thumping

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Vienna, April 22nd, 2013 -- The protective effect of inducing controlled hypothermia following sudden cardiac arrest will now be investigated in detail. The goal of the scientific work is to judge whether...

Biocrea to Develop a Human Neuron Screening Platform for the Discovery of Novel Treatments for Neurodegenerative Diseases With Neuroscientists From the Dresden University of Technology

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Radebeul, Germany, April 22, 2013 BioCrea GmbH, the first-in-class CNS drug discoveryspecialists validated through pharma partnerships, today announced the signing of a newcollaboration with the...

ICON-PLC and University College Dublin Smurfit School Launch the

Wed, 17 Apr 2013 12:00:00 AM GMT

Dublin, Ireland, 17 April, 2013 ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, in conjunction with University College Dublin (UCD), today announced the launch of the ICON Business Academy.

Developed with the UCD Michael Smurfit Graduate Business School, the ICON Business Academy offers a...

Bone Therapeutics and Erasme University Hospital Start Phase IIa Trial in Osteoporosis With Its Cell Therapy Product PREOB®

Tue, 16 Apr 2013 12:00:00 AM GMT

Gosselies, Belgium, 16 April 2013 - BONE THERAPEUTICS, the leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, announces today that its partner, the Rheumatology Department of Erasme University Hospital (Brussels, Belgium), has initiated a Phase IIa trial with its lead bone cell therapy product PREOB for the treatment of severe...

Avilex Pharma, a Spin Out Company From the University of Copenhagen, Announces Seed Investment From Novo Seeds

Mon, 15 Apr 2013 12:00:00 AM GMT

Copenhagen, April 15th, 2013 -- Avilex Pharma ApS today announced the raising of seed funding from Novo Seeds, the earlystage financing arm of Novo A/S to support the development of novel dimeric ligandstargeting PDZ domains. Based on the work of Professor Kristian Strmgaard, Dr. AndersBach and their team at the University of Copenhagen, the lead compounds provideunprecedented potency against...

InTech Partners With the American Society for Exosomes and Microvesicles to Publish Exosomes and Microvesicles Journal, an Open Access Publication

Fri, 12 Apr 2013 12:00:00 AM GMT

RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes principles, scientific research and clinical applications. The Exosomes and Microvesicles journal...

A*STAR, Unite Asean Health Experts in Fight Against Hand, Foot and Mouth Disease in the Region

Thu, 11 Apr 2013 12:00:00 AM GMT

April 11, 2013 -- 1. The Agency for Science, Technology and Research (A*STAR) and the Yong Loo Lin School of Medicine, NUS, are jointly organising the first ASEAN Hand, Foot and Mouth (HFMD) scientific workshop from 11th to 12th April. This inaugural workshop, conducted under the auspices of the ASEAN Committee on Science and Technology (COST) Health Flagship, is part of a greater vision...

A*STAR: Australia and Singapore Join Forces to Tackle Emerging Infectious Diseases

Wed, 10 Apr 2013 12:00:00 AM GMT

10 April 2013 -- Five research teams in Australia and Singapore awarded A*STAR-NHMRC joint grant to design ways to combat disease-causing bugs

1. The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia (NHMRC) and the Agency...

SARomics Biostructures: A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases

Wed, 10 Apr 2013 12:00:00 AM GMT

April 10, 2013 / B3C newswire / - SARomics Biostructures, Prestwick Chemical and ProQinase together with the University of Turin, Italy, the Israel Structural Proteomics Center (ISPC) at the Weizmann Institute of Science, Israel, and the TechMedIll platform of the University of Strasbourg, France, announce today that they have created the Translational Kinase Tumor Inhibitor Discovery Consortium ...

GlaxoSmithKline and A*STAR's to Develop New Medicines for Emerging Markets

Tue, 09 Apr 2013 12:00:00 AM GMT

1. Singapore, 9 April 2013 GlaxoSmithKline (GSK) and A*STARs Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (EBFs) specifically for emerging markets. EBFs are medicines which are reformulated to provide additional patient benefit.

2. ICES has a long standing relationship with GSK since 2003, and...

NanoSight Limited News: Trinity College Dublin Uses Nanoparticle Tracking Analysis to Develop Solutions for Diagnosis, Drug Delivery and Treatment of Cancer

Tue, 09 Apr 2013 12:00:00 AM GMT

Salisbury, UK, 9th April, 2013: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being applied in the development of future diagnostic and theranostic solutions for early diagnosis, drug delivery and treatment of cancer at the School of Medicine and CRANN, Trinity College Dublin, Ireland.

The School of Medicine (Institute of Molecular Medicine) and CRANN (the Centre for Research...

Isansys Lifecare Ltd. Announces Next-Stage Funding to Speed in-Hospital Wireless Patient Monitoring to Whole Patient Populations

Tue, 09 Apr 2013 12:00:00 AM GMT

Abingdon, United Kingdom, April 9th 2013 Isansys Lifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces that it has closed a major funding round with Isle of Man investors and has been awarded a grant from the Technology Strategy Boards Smart awards programme. The funds will accelerate the roll-out timetable into UK hospitals of the...

Abcam plc Licenses Novel Technology From Columbia University for Neurobiological Research

Mon, 08 Apr 2013 12:00:00 AM GMT

Bristol and Cambridge, UK, April 08, 2013: Abcam Plc., a producer and distributor of high quality protein research tools, and Columbia University, announced today that they have entered into an exclusive license agreement for two novel pH-responsive fluorescent false neurotransmitters (FFNs). FFNs are probes which act as optical tracers, allowing imaging of neurotransmitter release from individual...

Advantar Labs Expands East Coast Sales Presence

Mon, 08 Apr 2013 12:00:00 AM GMT

April 08, 2013 -- Advantar Labs, a contract laboratory provider, is pleased to announce the addition of Bill Blake as Northeast Business Development Director and Amy Bunn as Southeast Business Development Manager.

As part of our growth strategy in regions that continue to show strong drug development investment and activity, we are increasing our presence in the eastern United States....

A*STAR Scientist Awarded Prestigious Szent-Gyorgyi Prize for Progress in Cancer Research

Fri, 05 Apr 2013 12:00:00 AM GMT

April 05, 2013 -- 1. Professor Alex Matter, Chief Executive Officer of A*STARs Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyrgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

2. ...

Sanofi Pasteur Funds Research on Universal Flu Vaccine

Fri, 05 Apr 2013 12:00:00 AM GMT

by Richard Daverman, Editor

April 4, 2013 -- Sanofi Pasteur, the vaccines division of French pharma Sanofi, will fund research at Chinas Xiamen University with the goal of developing a universal flu vaccine. The joint effort, which will focus on broad-spectrum neutralization monoclonal antibodies, is already underway at Xiamen Universitys National Institute of Diagnostics and Vaccine Development...

Institute of Bioengineering and Nanotechnology Executive Director Professor Elected as 2013 Materials Research Society Fellow

Thu, 04 Apr 2013 12:00:00 AM GMT

Singapore, April 4, 2013 IBN Executive Director Professor Jackie Y. Ying was recently selected as a 2013 Materials Research Society (MRS) Fellow for her distinguished contributions to the synthesis of advanced nanostructured materials with unique functionalities for catalytic and biomaterial applications and for her distinguished service to the materials community. MRS is the worlds largest organization...

A*STAR Hosts Nobel Laureate and Renowned Stem Cell Expert Professor

Tue, 02 Apr 2013 12:00:00 AM GMT

April 02, 2013 -- Nobel Laureate Professor Shinya Yamanaka to give a lecture on latest progress in stem cell research at Biopolis and share insights on stem cell research with A*STAR scientific leaders.

1. Professor Shinya Yamanaka, Nobel Laureate in Medicine or Physiology 2012, has been invited to speak at Biopolis under the A*STAR Biomedical Research Council Distinguished Visitor...

Thermo Fisher Scientific Forms Technology Alliance Partnership With the University of Birmingham, UK

Thu, 28 Mar 2013 12:00:00 AM GMT

SAN JOSE, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a Technology Alliance Partner agreement with scientists at the University of Birmingham, UK, establishing a collaboration to accelerate research in high-resolution accurate mass (HRAM) and triple quadrupole liquid chromatography-mass spectrometry (LC-MS) for life science applications...

Singapore's UTAC to Co-Develop 2.5d Through-Silicon-Interposer With A*STAR's for Volume Manufacturing

Thu, 28 Mar 2013 12:00:00 AM GMT

1. Singapore, 28 March, 2013 - A*STARs Institute of Microelectronics (IME) and United Test and Assembly Center (UTAC), a leading outsourced assembly and test (OSAT) provider, have announced a collaboration to develop a 2.5D Through-Silicon-Interposer (TSI) platform which will enable UTAC to join the scarce list of suppliers in offering fine-pitch 2.5D TSI packaging solutions.

2. This collaboration...

A*STAR's and Fujikura Ltd. Demonstrate World's First 40 to 60 GBPS Silicon Photonics Modulator Using Advanced Modulation Formats

Wed, 27 Mar 2013 12:00:00 AM GMT

1. Singapore 27 March, 2013 -- In collaboration with Fujikura Ltd., researchers from Singapores A*STAR Institute of Microelectronics (IME) have pioneered the worlds first 40 to 60Gbps silicon-based optical modulators with advanced multilevel modulation formats for high speed long-haul data transmission. This represents a major advance towards low cost, ultra-high bandwidth and...

Procarta Biosystems Release: Fight Back Against MRSA to be Started With a Sniff

Mon, 25 Mar 2013 12:00:00 AM GMT

March 25, 2013 -- An innovative anti-bacterial spray that will kill just MRSA is being developed by Norwich Research Park scientists. The spray, which can be used in the nose to decolonise patients prior to major surgery, promises to speed recovery time and reduce the number of repeat operations.

Procarta Biosystems has developed a novel type of antibiotic specifically to treat MRSA and...

Institute of Microelectronics Kicks Off Copper Wire Bonding Consortium II to Tackle Copper Interconnects Reliability Issues

Mon, 25 Mar 2013 12:00:00 AM GMT

1. Singapore, 25 March, 2013 -- The Institute of Microelectronics (IME), a research institute of the Agency for Science, Technology and Research (A*STAR) in Singapore, has launched the Copper (Cu) Wire Bonding Consortium II. The consortium which rides on the successes of Phase I launched in 2010 aims to improve the reliability of semiconductor devices by tackling copper wire bonding issues related...

Nagasaki University and Astellas Pharma Inc. Launch Collaborative Research for Screening New Anti-Dengue Virus Drugs for Neglected Tropical Diseases

Thu, 21 Mar 2013 12:00:00 AM GMT

NAGASAKI, Japan & TOKYO--(BUSINESS WIRE)--The Nagasaki University ("Nagasaki University"; Nagasaki, Japan; President: Shigeru Katamine) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a collaborative research agreement to discover new drugs for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus...

Tokyo Institute of Technology and Astellas Pharma Inc. Launch Collaborative Research for New Anti-Dengue Virus Drugs for Neglected Tropical Diseases

Thu, 21 Mar 2013 12:00:00 AM GMT

TOKYO--(BUSINESS WIRE)--Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2.0 supercomputer to efficiently discover candidates for the treatment of neglected...

Element Six and the University of Warwick Announce Development of New Boron-Doped Synthetic Diamond Electrode for Extreme Electroanalysis Sensing Applications

Wed, 20 Mar 2013 12:00:00 AM GMT

PHILADELPHIAMar. 18, 2013AT PITTCON 2013, Element Six, the world leader in synthetic diamond supermaterials and member of the De Beers Group of Companies, today announced that it has engineered DIAFILM EA (Electroanalysis grade) in collaboration with The University of Warwick. The free-standing, solid boron doped microwave chemical vapor deposition (CVD) diamond electrode is expected to transform...

MRC Technology and Collaboration Yields Humanized Anti-CD146 Antibody

Tue, 19 Mar 2013 12:00:00 AM GMT

London, UK, 19 March 2013: MRC Technology, a technology transfer organisation, announced today that it has successfully humanized an anti-CD146 monoclonal antibody. The project forms part of an on-going collaboration between MRC Technology and the Institute of Biophysics, Chinese Academy of Sciences (IBP CAS) to develop the antibody as a cancer therapeutic.

The cell adhesion molecule CD...

Seward Stomacher® Contributes to Environmental Listeria Contamination Study

Tue, 19 Mar 2013 12:00:00 AM GMT

Worthing, UK 19 March 2013 Seward Limited, manufacturer and developer of the world leading, patented Stomacher Laboratory Paddle Blender range, has announced that its Stomacher 400 Circulator has been used in a recent study1 to evaluate environmental contamination by Listeria species. The increased interest in animal welfare and free range methods, such as pasture reared poultry, has made it important...

Oxford Gene Technology Ltd. Granted Licence by The Institute of Cancer Research, London, to Develop and Commercialise Prostate Cancer Biomarker Panel

Wed, 13 Mar 2013 12:00:00 AM GMT

Oxford, UK 13 March 2013 Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, announced today that it has been granted a licence by The Institute of Cancer Research (ICR), London, to further develop and commercialise a new panel of diagnostic and prognostic microRNA biomarkers for prostate cancer. The agreement follows a three...

A*STAR Scientists Discover "Switch" Critical to Wound Healing

Fri, 08 Mar 2013 12:00:00 AM GMT

March 08, 2013 -- Patients with diseases such as diabetes suffer from painful wounds that take a long time to heal making them more susceptible to infections that could even lead to amputations. A*STARs discovery paves the way for therapeutics to improve healing of such chronic wounds, which are a significant burden to patients.

1. Scientists from A*STARs Institute of Medical...

Sun Yat-Sen University, Johns Hopkins University Partner to Develop Medical Researchers

Fri, 08 Mar 2013 12:00:00 AM GMT

by Richard Daverman, PhD

March 8, 2013 -- Sun Yat-sen University and its hospitals will collaborate with Johns Hopkins University to develop Chinas next-generation clinical investigators. The two academic medical institutions will create a platform for exchanges among clinical and translational investigators, research professionals and administrators in both the US and China. The goal is...

Scientists at A*STAR's Genome Institute of Singapore Catch Evolving Germs and Cancer Cells Early

Thu, 07 Mar 2013 12:00:00 AM GMT

March 7, 2013 -- Scientists at A*STARs Genome Institute of Singapore (GIS) have developed a novel technique to precisely monitor and study the evolution of micro-organisms such as viruses and bacteria. This is an extremely important capability as it allows scientists to investigate if new drugs designed to kill them are working, and catch the development of resistance early on.

Micro-organisms...

Fight Back Against MRSA to be Started With a Sniff, Study

Thu, 07 Mar 2013 12:00:00 AM GMT

March 07, 2013 -- An innovative anti-bacterial spray that will kill just MRSA is being developed by Norwich Research Park scientists. The spray, which can be used in the nose to decolonise patients prior to major surgery, promises to speed recovery time and reduce the number of repeat operations.

Procarta Biosystems has developed a novel type of antibiotic specifically to treat MRSA and...

Kuopio University Hospital First in Finland With Elekta AB's New Beam Shaping Innovation for Radiotherapy of Cancer Patients

Wed, 06 Mar 2013 12:00:00 AM GMT

KUOPIO, Finland--(BUSINESS WIRE)--Regulatory News: In the spring of 2013, Kuopio University Hospital (KUH, Kuopio, Finland) will take a leap forward in radiation therapy capabilities when the center begins treating patients with its two new Elekta (STO:EKTAB) Infinity treatment systems equipped with the revolutionary Agility 160-leaf multileaf collimator (MLC). The two Elekta therapy systems will...

Melbourne's Bowel Cancer Research Could Potentially Save Thousands of UK Lives, Walter and Eliza Hall Institute of Medical Research Study

Fri, 01 Mar 2013 12:00:00 AM GMT

Melbourne, 29 February 2013: Researchers at the Walter and Eliza Hall Institute in Melbourne have identified a potential new treatment for a variety of colon and gastric cancers, which could prove highly important for preventing thousands of deaths around the world.

Associate Professor Ernst and Dr Stefan Thiem from the Institutes Cell Signalling and Cell Death division in Melbourne identified...

VIB: New Angle to Combat Malignant Brain Tumors in Children

Thu, 28 Feb 2013 12:00:00 AM GMT

February 28, 2013 -- A medulloblastoma is a malignant brain tumor that occurs primarily in children and is currently untreatable. Peter Carmeliet and his team (VIB-KU Leuven) joined forces with scientists at Massachusetts General Hospital in Harvard to study the role of the placental growth factor (PIGF) in the growth of this brain tumor. They demonstrated that blocking PIGF inhibits the growth and...

Roche Research Sheds Light on Improving Neurological Deficits in Mouse Model of Down Syndrome

Wed, 27 Feb 2013 12:00:00 AM GMT

NUTLEY, NJ -- February 27, 2013 -- Today, Roche scientists, along with scientists at the University of Cantabria and Spains Cajal Institute, report findings in the Journal of Neurosciencea, which demonstrate that by selectively blocking specific receptors in the brain they were able to reverse key neurological deficits in a mouse model of Down syndrome (the Ts65Dn mouse). Using an investigational...

Institute of Bioengineering and Nanotechnology Creates Unlimited Source of Human Kidney Cells

Thu, 21 Feb 2013 12:00:00 AM GMT

Singapore, February 21, 2013 Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have successfully generated human kidney cells from human embryonic stem cells in vitro1. Specifically, they produced the renal cells under artificial conditions in the lab without using animals or organs. This has not been possible until now.According to IBN Executive Director, Professor Jackie...

A*STAR's and Stanford University to Jointly Develop "Switch Technology" for Higher Energy Efficiency in Mobile Devices and Digital Systems

Fri, 15 Feb 2013 12:00:00 AM GMT

February 15, 2013 -- 1. Singapore, 15 Feb 2013 - A*STARs Institute of Microelectronics (IME) and Stanford University will collaborate to advance innovations in nano-electromechanical systems (NEMS) switch technology for ultra low power digital systems. The use of NEMS switches in digital systems such as laptops and smart phones can extend operational time of existing batteries, thereby increasing...

A*STAR's Genome Institute of Singapore Develops Advanced Method to Study Epigenome of Cells Essential for Normal Growth and Development

Wed, 13 Feb 2013 12:00:00 AM GMT

13 February 2013 -- Scientists at A*STARs Genome Institute of Singapore (GIS) have successfully developed a method to map the epigenome using 100 times fewer cells than was previously possible. The discovery, published in the journal Developmental Cell, means that it is now possible to study the epigenome of parts of the body with rare cell populations such as germ cells (which differentiate into...

A New Study Suggests Deep Brain Stimulation (DBS) is Now Beneficial in Earlier Stages of Parkinson's Disease, Study Published in

Wed, 13 Feb 2013 12:00:00 AM GMT

MILWAUKEE, WI A study published today in the New England Journal of Medicine shows that the use of deep brain stimulation (DBS) in earlier stages of Parkinsons disease significantly improves the overall quality of life and social functioning in patients.

This German-French study (EARLYSTIM), led by Prof. Gnther Deuschl, Kiel, Germany, and Prof. Yves Agid, Paris, France, demonstrates results...

Carl Zeiss Attracting the Next Generation of Research Scientists

Wed, 13 Feb 2013 12:00:00 AM GMT

February 13, 2013 -- Much has been said of the fact that American students are falling behind in science; minority students in particular are under-represented and do not tend to choose science as a career path. One doctor and research scientist, with a longstanding interest in education and training, was determined to change this pattern. He established a unique training program that brings minority...

Polymer Nanoparticles Used as Drug Carriers Characterized Using Nanoparticle Tracking Analysis at Saarbrucken

Tue, 12 Feb 2013 12:00:00 AM GMT

Salisbury, UK, 12th February 2013: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is used to help with the characterization of polymeric nanoparticles synthesized as drug carrier systems. This work is being carried out at Saarland University, Saarbrcken in Germany by Dr Christian Ruge and his colleagues.

In the world of pharmaceutical sciences, a detailed and full characterization...

Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease"

Tue, 12 Feb 2013 12:00:00 AM GMT

PRLog (Press Release) - Feb. 12, 2013 - MONMOUTH JUNCTION, NJ. Inventors Iwakura Yoichiro, Kakuta Shigeru and Suzuki, Shunsuke and assignee The University of Tokyo published United States Patent Application 20130011413 titled, Method and Pharmaceutical Composition for Treatment of Intestinal Disease. The patient details a method for using interleukin-related substances like an IL-17F inhibitor typified...

Drugmakers Including Bayer AG, AstraZeneca PLC and Johnson & Johnson Pool R&D in $265 Million EU Project

Mon, 11 Feb 2013 12:00:00 AM GMT

Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new 196 million euros ($265 million) project designed to find tomorrow's medicines. The project, backed by the European Union, is the latest example of the drugs industry exploring ways to share early-stage research, effectively taking lessons from the kind of open innovation that gave the...

A*STAR's Genome Institute of Singapore Develops Advanced Method to Study Epigenome of Cells Essential for Normal Growth and Development

Mon, 11 Feb 2013 12:00:00 AM GMT

February 11, 2013 -- Scientists at A*STARs Genome Institute of Singapore (GIS) have successfully developed a method to map the epigenome using 100 times fewer cells than was previously possible. The discovery, published in the journal Developmental Cell, means that it is now possible to study the epigenome of parts of the body with rare cell populations such as germ cells (which differentiate into...

A*STAR Scientists Make Groundbreaking Discovery of Cell Nucleus Structure Crucial to Understanding Diseases

Fri, 08 Feb 2013 12:00:00 AM GMT

None, Feb 8, 2013 (JCN Newswire) - Singapore, Feb 8, 2013 - (ACN Newswire) - Scientists from Singapore and Germany have identified that the proteins lamin A (Lmna) and lamin B receptor (Lbr) are essential for holding silent genes in their correct position at the edge of the nucleus, in the form of heterochromatin(1). A deviation from their normal position will cause the genes to malfunction, leading...

Summit Corporation and Enter Utrophin Biomarker Collaboration for Duchenne Muscular Dystrophy

Wed, 06 Feb 2013 12:00:00 AM GMT

Oxford, UK, 6 February 2013 Summit (AIM: SUMM), a drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy (DMD) and C. difficile infections, announces that it has entered into a collaboration with Dr Yetrib Hathout from Childrens National Medical Center in Washington DC, for the development of utrophin biomarkers for DMD. The collaboration is being financially...

Aeras/Oxford University Development of TB Vaccine Hits Snag

Tue, 05 Feb 2013 12:00:00 AM GMT

LONDON--(BUSINESS WIRE)--Data were published in The Lancet today from a Phase IIb clinical trial evaluating the safety and efficacy of MVA85A in preventing tuberculosis (TB) in infants. MVA85A is a TB vaccine candidate designed to boost immune responses already primed by the Bacille Calmette-Gurin (BCG) vaccine, the currently licensed and widely used TB vaccine.

Data show that a single dose...

Karolinska Development AB Signs Agreement With Mayo Clinic

Mon, 04 Feb 2013 12:00:00 AM GMT

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Karolinska Development AB (publ) (STO:KDEV) has entered into an agreement with Mayo Clinic with the aim of identifying commercialization opportunities in Mayos life science innovations that will improve patient care. Through this agreement, Karolinska Development will evaluate innovations from Mayo Clinic. The collaboration will increase the possibilities...

A*STAR Scientists Solve Century-Old Mystery by Finding Stable Haploid Strains of Candida Albicans - a Major Cause of Hospital Acquired Infection

Fri, 01 Feb 2013 12:00:00 AM GMT

February 1, 2013 -- 1. A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) have identified what eluded yeast scientists for the past 100 years, by constructing stable haploid strains of Candida albicans, the most prevalent human fungal pathogen. This discovery, jointly made by two teams of scientists led by Prof Wang Yue of IMCB and Prof Judith Berman of the University of Minnesota...

MagForce Nanotechnologies Starts Research Project With

Thu, 31 Jan 2013 12:00:00 AM GMT

BERLIN, GERMANY--(Marketwire - January 31, 2013) -

MagForce AG /MagForce starts research project with University of Bremen. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

* Project to develop magnetic iron oxide particles with improvedefficiency

* Agreement on funding by...

MicroConstants China to Manage Clinical Research Center at #307 Hospital

Thu, 31 Jan 2013 12:00:00 AM GMT

by Richard Daverman, PhD

January 31, 2013 -- MicroConstants China, a Beijing CRO that offers preclinical pharmacokinetic studies, early-stage clinical trials, and regulated bioanalysis, signed a strategic collaboration agreement to manage the clinical research center of the No. 307 Hospital of the Peoples Liberation Army. The parent of MicroConstants China is headquartered in San Diego...

A*STAR's Collaborates With on Mems Sensor for Oil and Gas Applications

Thu, 31 Jan 2013 12:00:00 AM GMT

1. Singapore, 31 January, 2013 A*STARs Institute of Microelectronics has signed an agreement to collaborate with Petroleum Geo-Services (OSE:PGS), a focused geophysical company headquartered in Oslo, Norway, to develop a high performance Micro-Electromechanical Systems (MEMS) based sensor for deep sea seismic oil and gas exploration. The MEMS sensor is targeted for incorporation...

Medical University in Graz: Skin-Deep Communication: Messenger Substance and Signalling Molecule Influence the Development of the Skin's Immune Cells